New hope for kids with tough leukemia: gentler chemo trial launches
Disease control
Recruiting now
This study is testing whether swapping two specific chemotherapy cycles in the standard treatment for children with acute myeloid leukemia (AML) is safe and tolerable. The goal is to achieve similar or better survival rates while potentially reducing the risk of severe long-term …
Phase: EARLY_PHASE1 • Sponsor: Joanna Yi • Aim: Disease control
Last updated Mar 19, 2026 14:55 UTC